-- 紅木信託(Redwood Trust,RWT)和卡斯萊克(Castlelake)已達成協議,將成立一家合資企業,收購高達80億美元的優質巨額抵押貸款。卡斯萊克週三宣布了這一消息。 卡斯萊克表示,根據該合資協議,紅木信託旗下的Sequoia平台將負責尋找、匯總並盡職調查符合既定資格標準的貸款。 合資企業的財務細節尚未披露。 紅木信託的股價在周三的交易中下跌了2.2%。
Price: $5.63, Change: $-0.12, Percent Change: -2.09%
-- 紅木信託(Redwood Trust,RWT)和卡斯萊克(Castlelake)已達成協議,將成立一家合資企業,收購高達80億美元的優質巨額抵押貸款。卡斯萊克週三宣布了這一消息。 卡斯萊克表示,根據該合資協議,紅木信託旗下的Sequoia平台將負責尋找、匯總並盡職調查符合既定資格標準的貸款。 合資企業的財務細節尚未披露。 紅木信託的股價在周三的交易中下跌了2.2%。
Price: $5.63, Change: $-0.12, Percent Change: -2.09%
Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%
Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.